Table 2.
Description of observed (actual) sequences in the sample
| Care sequences | Numbers | Percentage |
|---|---|---|
|
Care provision for non-metastatic breast cancer in case of good prognosis (Figure 1 a) |
81 |
51% |
| ADR |
47 |
30% |
| AD |
16 |
10% |
| DR |
13 |
8% |
| D |
5 |
3% |
|
Care provision for non-metastatic breast cancer in case of presence of factors for poor prognosis (Figure 1 b) |
54 |
34% |
| ADKR |
42 |
26% |
| ADKOK |
8 |
6% |
| DKR |
2 |
1% |
| DKOK |
2 |
1% |
|
Care provision for non-metastatic breast cancer in case of voluminous, infiltrating and/or inflammatory cancer (Figure 1 c) |
8 |
5% |
| ANDR |
8 |
5.0 |
|
Other (non standard sequences) |
16 |
10% |
| A |
6 |
5% |
| ADK |
2 |
0-1% |
| AK |
2 |
0-1% |
| AR |
2 |
0-1% |
| ADKDR |
1 |
0-1% |
| ANDRK |
1 |
0-1% |
| DK |
1 |
0-1% |
| DKDKOK | 1 | 0-1% |
A Pathology investigation.
D Surgery and pathology examination of the surgical pieces.
N Neo-adjuvant chemotherapy.
K Chemotherapy.
R Radiotherapy.
O Concomitant chemotherapy and radiotherapy.